UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Anti-PD-1 Immunotherapy in Preclinical GL261 Glioblastoma: Influence of Therapeutic Parameters and Non-Invasive Response Biomarker Assessment with MRSI-Based Approaches

International journal of molecular sciences, 2020-11, Vol.21 (22), p.8775

2020

Link zum Volltext

Verfügbarkeit prüfen

Cancer metabolism in a snapshot: MRS(I)

NMR in biomedicine, 2019-10, Vol.32 (10), p.e4054-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Establishing Imaging Biomarkers of Host Immune System Efficacy during Glioblastoma Therapy Response: Challenges, Obstacles and Future Perspectives

Metabolites, 2022-03, Vol.12 (3), p.243

2022

Link zum Volltext

Verfügbarkeit prüfen

Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?

Cancers, 2022-10, Vol.14 (19), p.4960

2022

Link zum Volltext

Verfügbarkeit prüfen

Robust Conditional Independence maps of single-voxel Magnetic Resonance Spectra to elucidate associations between brain tumours and metabolites

PloS one, 2020-07, Vol.15 (7), p.e0235057-e0235057

2020

Link zum Volltext

Verfügbarkeit prüfen

Up-Regulation of the Alpha Prime Subunit of Protein Kinase CK2 as a Marker of Fast Proliferation in GL261 Cultured Cells

Pathology oncology research, 2019-10, Vol.25 (4), p.1659-1663

2019

Link zum Volltext

Verfügbarkeit prüfen

Brain metabolic pattern analysis using a magnetic resonance spectra classification software in experimental stroke

BMC neuroscience, 2017-01, Vol.18 (1), p.13-13, Article 13

2017

Link zum Volltext

Verfügbarkeit prüfen

Metabolomics of Therapy Response in Preclinical Glioblastoma: A Multi-Slice MRSI-Based Volumetric Analysis for Noninvasive Assessment of Temozolomide Treatment

Metabolites, 2017-05, Vol.7 (2), p.20

2017

Link zum Volltext

Verfügbarkeit prüfen

Bioinspired Theranostic Coordination Polymer Nanoparticles for Intranasal Dopamine Replacement in Parkinson’s Disease

ACS nano, 2021-05, Vol.15 (5), p.8592-8609

2021

Link zum Volltext

Verfügbarkeit prüfen

Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly

International journal of molecular sciences, 2023-01, Vol.24 (2), p.1273

2023

Link zum Volltext

Verfügbarkeit prüfen

Immune System-Related Changes in Preclinical GL261 Glioblastoma under TMZ Treatment: Explaining MRSI-Based Nosological Imaging Findings with RT-PCR Analyses

Cancers, 2021-05, Vol.13 (11), p.2663

2021

Link zum Volltext

Verfügbarkeit prüfen

Embedding MRI information into MRSI data source extraction improves brain tumour delineation in animal models

PloS one, 2019-08, Vol.14 (8), p.e0220809-e0220809

2019

Link zum Volltext

Verfügbarkeit prüfen

Anti‐tumour immune response in GL261 glioblastoma generated by Temozolomide Immune‐Enhancing Metronomic Schedule monitored with MRSI‐based nosological images

NMR in biomedicine, 2020-04, Vol.33 (4), p.e4229-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide

NMR in biomedicine, 2017-09, Vol.30 (9), p.n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Unraveling response to temozolomide in preclinical GL261 glioblastoma with MRI/MRSI using radiomics and signal source extraction

Scientific reports, 2020-11, Vol.10 (1), p.19699, Article 19699

2020

Link zum Volltext

Verfügbarkeit prüfen

Correlation of MR-Based Metabolomics and Molecular Profiling in the Tumor Microenvironment of Temozolomide-Treated Orthotopic GL261 Glioblastoma in Mice

International journal of molecular sciences, 2023-12, Vol.24 (24), p.17628

2023

Link zum Volltext

Verfügbarkeit prüfen

Tracking Therapy Response in Glioblastoma Using 1D Convolutional Neural Networks

Cancers, 2023-08, Vol.15 (15), p.4002

2023

Link zum Volltext

Verfügbarkeit prüfen

Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?

Nanomaterials (Basel, Switzerland), 2023-05, Vol.13 (10), p.1619

2023

Link zum Volltext

Verfügbarkeit prüfen

Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice

Pharmaceuticals (Basel, Switzerland), 2017-02, Vol.10 (1), p.24

2017

Link zum Volltext

Verfügbarkeit prüfen

Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation

Journal of neuro-oncology, 2016-08, Vol.129 (1), p.67-76

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficient γ-amino-proline-derived cell penetrating peptide-superparamagnetic iron oxide nanoparticle conjugates via aniline-catalyzed oxime chemistry as bimodal imaging nanoagents

Chemical communications (Cambridge, England), 2012-05, Vol.48 (43), p.5322-5324

2012

Link zum Volltext

Verfügbarkeit prüfen

In Vivo and Ex Vivo Magnetic Resonance Spectroscopy of the Infarct and the Subventricular Zone in Experimental Stroke

Journal of cerebral blood flow and metabolism, 2015-05, Vol.35 (5), p.828-834

2015

Link zum Volltext

Verfügbarkeit prüfen

Prospective diagnostic performance evaluation of single-voxel 1H MRS for typing and grading of brain tumours

NMR in biomedicine, 2012-04, Vol.25 (4), p.661-673

2012

Link zum Volltext

Verfügbarkeit prüfen

Molecular imaging coupled to pattern recognition distinguishes response to temozolomide in preclinical glioblastoma

NMR in biomedicine, 2014-11, Vol.27 (11), p.1333-1345

2014

Link zum Volltext

Verfügbarkeit prüfen

Protein Kinase CK2 Content in GL261 Mouse Glioblastoma

Pathology oncology research, 2016-07, Vol.22 (3), p.633-637

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(51)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Nmr In Biomedicine
(6)
Cancers
(4)
International Journal Of Molecular Sciences
(3)
Journal Of Nanotechnology
(3)
Magma
(3)
Metabolites
(2)
Nanomaterials
(2)
Omics
(2)
Pathology Oncology Research
(2)
Plos One
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Anti-PD-1 Immunotherapy in Preclinical GL261 Glioblastoma: Influence of Therapeutic Parameters and Non-Invasive Response Biomarker Assessment with MRSI-Based Approaches

Cancer metabolism in a snapshot: MRS(I)

Establishing Imaging Biomarkers of Host Immune System Efficacy during Glioblastoma Therapy Response: Challenges, Obstacles and Future Perspectives

Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?

Robust Conditional Independence maps of single-voxel Magnetic Resonance Spectra to elucidate associations between brain tumours and metabolites

Up-Regulation of the Alpha Prime Subunit of Protein Kinase CK2 as a Marker of Fast Proliferation in GL261 Cultured Cells

Brain metabolic pattern analysis using a magnetic resonance spectra classification software in experimental stroke

Metabolomics of Therapy Response in Preclinical Glioblastoma: A Multi-Slice MRSI-Based Volumetric Analysis for Noninvasive Assessment of Temozolomide Treatment

Bioinspired Theranostic Coordination Polymer Nanoparticles for Intranasal Dopamine Replacement in Parkinson’s Disease

Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly

Immune System-Related Changes in Preclinical GL261 Glioblastoma under TMZ Treatment: Explaining MRSI-Based Nosological Imaging Findings with RT-PCR Analyses

Embedding MRI information into MRSI data source extraction improves brain tumour delineation in animal models

Anti‐tumour immune response in GL261 glioblastoma generated by Temozolomide Immune‐Enhancing Metronomic Schedule monitored with MRSI‐based nosological images

Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide

Unraveling response to temozolomide in preclinical GL261 glioblastoma with MRI/MRSI using radiomics and signal source extraction

Correlation of MR-Based Metabolomics and Molecular Profiling in the Tumor Microenvironment of Temozolomide-Treated Orthotopic GL261 Glioblastoma in Mice

Tracking Therapy Response in Glioblastoma Using 1D Convolutional Neural Networks

Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?

Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice

Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation

Efficient γ-amino-proline-derived cell penetrating peptide-superparamagnetic iron oxide nanoparticle conjugates via aniline-catalyzed oxime chemistry as bimodal imaging nanoagents

In Vivo and Ex Vivo Magnetic Resonance Spectroscopy of the Infarct and the Subventricular Zone in Experimental Stroke

Prospective diagnostic performance evaluation of single-voxel 1H MRS for typing and grading of brain tumours

Molecular imaging coupled to pattern recognition distinguishes response to temozolomide in preclinical glioblastoma

Protein Kinase CK2 Content in GL261 Mouse Glioblastoma

Suchergebnisse filtern